News
IMAX (IMAX) Q3 2023 Earnings Call Transcript
My Take: 4 Strong Growth Stocks to Buy This Week
There's never a slow week on Wall Street, but things will be particularly busy in the next few days. Earnings season is heating up with hundreds of companies reporting quarterly results on some
3 Growth Stocks That Could Make You Richer by 2030
Growth stocks gave investors a wild ride over the last few years. After soaring for most of the last decade, the Nasdaq Composite fell hard in 2022. While the index is up 29% this year, many growth
Why IMAX Stock Trounced the Market Today
Big-screen movie technology company IMAX (NYSE: IMAX) was a hit with investors Thursday. This wasn't exactly a surprise, as it released estimate-busting quarterly results that featured some beefy
IMAX (IMAX) Q2 2023 Earnings Call Transcript
Can Movie Theater Stocks Keep the Barbenheimer Rally Going?
This was the weekend that multiplex operators have been waiting for. Not one but two huge films opened at the same time. There are also a couple of older movies with legs, something that has been
Why Imax Stock Blasted Nearly 6% Higher on Thursday
An expanding strike by talent in the film and TV industry didn't dissuade investors from piling into Imax (NYSE: IMAX) stock on Thursday. Shares of the big-screen entertainment purveyor rose by just
Google Pixel Buds Pro: Premium-Sound und Stille zum Schnäppchenpreis
Nutze JETZT das Top-Angebot: Soundcore Anker Motion Boom Plus – Der IP67 Outdoor-Lautsprecher mit Powerbank-Funktion für nur 119,99€!
Sichere Dir jetzt den soundcore by Anker Boom 2 Outdoor-Lautsprecher zum unschlagbaren Preis!
Sichere dir jetzt den soundcore by Anker Q30: Top-Noise-Cancelling und beeindruckender Klang zum unschlagbaren Preis!
IMAX: How It’s Still Cashing In on the Movie Business
IMAX Co. (NYSE: IMAX) owns and operates a technology platform that specializes in enhancing cinematic experiences. Contrary to popular belief, IMAX doesn't operate cinemas or movie theaters
Behandlung mit CARVYKTI®▼(ciltacabtagene autoleucel) führte zu klinisch bedeutsamen Verbesserungen der gesundheitsbezogenen Lebensqualität und zu einer Verringerung krankheitsspezifischer Symptome bei Patienten mit multiplem Myelom in der Frühphase
Mündliche Präsentationen auf der ASH-Jahrestagung 2023, darunter die von den Patienten berichteten Ergebnisse der CARTITUDE-4-Studie sowie längerfristige Wirksamkeits- und Sicherheitsdaten der
Equinitis Investition in Simulationstraining bringt den Call-Centern einen signifikanten ROI
Die spielbasierte Lernlösung von Attensi hat große Auswirkungen auf das globale Geschäft im Bereich der Aktienregistrierung.
COLOGNE, Germany, April 19, 2023 (GLOBE NEWSWIRE) -- Training, das auf